SAN
DIEGO, Aug. 30, 2023 /PRNewswire/ -- NuVasive,
Inc. (NASDAQ: NUVA), the leader in spine technology innovation,
focused on transforming spine surgery with minimally disruptive,
procedurally integrated solutions, today announced it will continue
its partnership with the Scoliosis Research Society (SRS) as a
double diamond sponsor and will attend the 58th Annual
Meeting held September 6-9, 2023, in
Seattle.
"We partner with esteemed societies like SRS because of our
shared dedication to clinical research, education, and thought
leadership around advancing patient care, especially in the
challenging deformity segment," said Chris
Barry, chief executive officer at NuVasive. "SRS amplifies
our potential to transform complex spine surgery with more
intelligent and procedurally integrated deformity solutions."
As part of the SRS Annual Meeting, NuVasive will host
a workshop on September 7, 2023,
titled "Complex Junctional Strategies—The Good, The Bad and The
Ugly" presented by faculty members Dr. Han
Jo Kim, Dr. Tyler Koski, and
Dr. Chris Shaffrey, and moderated by
Dr. Rajiv Sethi. This
case-based discussion will cover the panel's experiences with their
deformity patients and practices.
NuVasive has partnered with SRS, the premier international
society aimed at fostering optimal care for all patients with
spinal deformities, since 2007. The Company's ongoing double
diamond sponsorship supports clinical workshops, hands-on
educational courses, fellowships, and grants for more than 1,500 of
the world's leading spine surgeons, researchers, physician
assistants, and orthotists involved in researching and treating
spinal deformities.
About NuVasive
NuVasive,
Inc. (NASDAQ: NUVA) is the leader in spine technology
innovation, with a mission to transform surgery, advance care, and
change lives. The Company's less-invasive, procedurally integrated
surgical solutions are designed to deliver reproducible and
clinically proven outcomes. The Company's comprehensive procedural
portfolio includes surgical access instruments, spinal implants,
fixation systems, biologics, software for surgical planning,
navigation and imaging solutions, magnetically adjustable implant
systems for spine and orthopedics, and intraoperative
neuromonitoring technology and service offerings. With more
than $1 billion in net sales, NuVasive operates
in more than 50 countries serving surgeons, hospitals, and
patients. For more information, please
visit www.nuvasive.com.
Forward-Looking
Statements
NuVasive cautions you that statements
included in this news release that are not a description of
historical facts are forward-looking statements that involve risks,
uncertainties, assumptions and other factors which, if they do not
materialize or prove correct, could
cause NuVasive's results to differ materially from
historical results or those expressed or implied by such
forward-looking statements. The potential risks and uncertainties
which contribute to the uncertain nature of these statements
include, among others, risks associated with acceptance of the
Company's surgical products and procedures by spine surgeons and
hospitals, development and acceptance of new products or product
enhancements, clinical and statistical verification of the benefits
achieved via the use of NuVasive's products, the
Company's ability to adequately manage inventory as it continues to
release new products, its ability to recruit and retain management
and key personnel, and the other risks and uncertainties described
in NuVasive's news releases and periodic filings with
the Securities and Exchange
Commission. NuVasive's public filings with
the Securities and Exchange Commission are available at
www.sec.gov. NuVasive assumes no obligation to update any
forward-looking statement to reflect events or circumstances
arising after the date on which it was made.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nuvasive-to-participate-as-double-diamond-sponsor-at-scoliosis-research-society-annual-meeting-301912888.html
SOURCE NuVasive, Inc.